ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,648.74
      0.31%
      US Tech 100
      19,764.00
      -0.41%
      Dow Jones
      40,830.84
      1.54%
      Brent Oil
      83.645
      -0.82%
      Bitcoin
      64,601.03
      -0.39%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. (MM) (DRTX)

      7. (MM) (DRTX) News

      DRTX

      (MM) (DRTX)

      (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:DRTX
      DateTimeSourceHeadlineSymbolCompany
      10/18/20124:30PMBusiness WireDurata Therapeutics Presents Results from Skin Lesion Measurement Study at IDWeek 2012NASDAQ:DRTX(MM)
      10/18/20124:22PMBusiness WireDurata Therapeutics Announces Preclinical Data Supporting Clinical Development of Dalbavancin for the Treatment of PneumoniaNASDAQ:DRTX(MM)
      10/15/20127:45AMBusiness WireDurata Therapeutics Names Allison Wey as Vice President, Investor Relations and Public AffairsNASDAQ:DRTX(MM)
      10/05/20122:44PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (S-8)NASDAQ:DRTX(MM)
      10/04/20127:45AMBusiness WireDurata Therapeutics Presenting Two Abstracts Concerning Dalbavancin at IDWeek 2012NASDAQ:DRTX(MM)
      10/03/20127:45AMBusiness WireDurata Therapeutics to Present at 11th Annual BIO Investor ForumNASDAQ:DRTX(MM)
      09/27/20122:46PMDow Jones NewsIPO Scorecard: Update on Selected Initial Stock OfferingsNASDAQ:DRTX(MM)
      09/26/20123:06PMDow Jones NewsIPO Scorecard: Update on Selected Initial Stock OfferingsNASDAQ:DRTX(MM)
      09/25/20123:03PMDow Jones NewsIPO Scorecard: Update on Selected Initial Stock OfferingsNASDAQ:DRTX(MM)
      09/24/20122:44PMDow Jones NewsIPO Scorecard: Update on Selected Initial Stock OfferingsNASDAQ:DRTX(MM)
      09/21/20122:55PMDow Jones NewsIPO Scorecard: Update on Selected Initial Stock OfferingsNASDAQ:DRTX(MM)
      09/20/20123:11PMDow Jones NewsIPO Scorecard: Update on Selected Initial Stock OfferingsNASDAQ:DRTX(MM)
      09/19/20122:50PMDow Jones NewsIPO Scorecard: Update on Selected Initial Stock OfferingsNASDAQ:DRTX(MM)
      09/18/20122:57PMDow Jones NewsIPO Scorecard: Update on Selected Initial Stock OfferingsNASDAQ:DRTX(MM)
      09/17/20122:47PMDow Jones NewsIPO Scorecard: Update on Selected Initial Stock OfferingsNASDAQ:DRTX(MM)
      09/14/20123:05PMDow Jones NewsIPO Scorecard: Update on Selected Initial Stock OfferingsNASDAQ:DRTX(MM)
      09/13/20122:59PMDow Jones NewsIPO Scorecard: Update on Selected Initial Stock OfferingsNASDAQ:DRTX(MM)
      09/12/20122:49PMDow Jones NewsIPO Scorecard: Update on Selected Initial Stock OfferingsNASDAQ:DRTX(MM)
      09/11/20122:51PMDow Jones NewsIPO Scorecard: Update on Selected Initial Stock OfferingsNASDAQ:DRTX(MM)
      09/11/20127:45AMBusiness WireDurata Therapeutics Announces Completion of QT Study of DalbavancinNASDAQ:DRTX(MM)
      09/10/20122:51PMDow Jones NewsIPO Scorecard: Update on Selected Initial Stock OfferingsNASDAQ:DRTX(MM)
      09/10/20127:45AMBusiness WireData Showing Potential Economic Benefits of Treating ABSSSI in Outpatient Settings Presented at ICAAC 2012NASDAQ:DRTX(MM)
      09/10/20127:45AMBusiness WireNew Data Demonstrating Potency of Durata Therapeutics’ Dalbavancin Against Bacterial Pathogens Presented at ICAAC 2012NASDAQ:DRTX(MM)
      09/07/20123:07PMDow Jones NewsIPO Scorecard: Update on Selected Initial Stock OfferingsNASDAQ:DRTX(MM)
      09/06/20123:09PMDow Jones NewsIPO Scorecard: Update on Selected Initial Stock OfferingsNASDAQ:DRTX(MM)
      09/06/20127:45AMBusiness WireDurata Therapeutics Completes Target Enrollment in Phase 3 DISCOVER 1 Clinical Trial Comparing Dalbavancin to Vancomycin & Li...NASDAQ:DRTX(MM)
      09/05/20123:11PMDow Jones NewsIPO Scorecard: Update on Selected Initial Stock OfferingsNASDAQ:DRTX(MM)
      09/04/20122:45PMDow Jones NewsIPO Scorecard: Update on Selected Initial Stock OfferingsNASDAQ:DRTX(MM)
      09/04/20128:54AMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:DRTX(MM)
      09/04/20128:45AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:DRTX(MM)
       Showing the most relevant articles for your search:NASDAQ:DRTX

      Your Recent History

      BIT
      P1W9B4
      NLBNPIT1W9B4 20351221 4....
      Delayed Upgrade Clock